Related Experiment Videos

[Hepatobiliary complications in chronic intestinal inflammatory disease]

X Bertrán¹, R Planas

¹Servicio de Aparato Digestivo, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona.

Gastroenterologia Y Hepatologia

|January 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

Alimentary pharmacology & therapeutics·2016

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

HIV medicine·2013

Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C.

Alimentary pharmacology & therapeutics·2013

Determinants of plasma Fatty Acid abnormalities in patients with active inflammatory bowel disease: a multivariate analysis.

Inflammatory bowel diseases·2013

Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.

Journal of hepatology·2011

A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment.

Journal of viral hepatitis·2010

See all related articles